MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$22,377K
(-39.51%↓ Y/Y)
Hiv
$13,019K
(0.92%↑ Y/Y)
Molecular Products
$9,058K
(-0.57%↓ Y/Y)
Hcv
$2,663K
(-38.54%↓ Y/Y)
Other Product And
Services Revenues
$1,618K
(109.31%↑ Y/Y)
COVID19
$18K
(-96.10%↓ Y/Y)
Loss before equity
investment
-$21,289K
Loss on equity
investment
-$1,088K
(-107.63%↓ Y/Y)
Income tax benefit
-$432K
(5.26%↑ Y/Y)
Sales
$26,376K
(-9.04%↓ Y/Y)
Other Income-Other
Non Product...
$1,549K
(65.85%↑ Y/Y)
Loss before income
taxes and equity...
-$21,721K
(-35.99%↓ Y/Y)
Other income
$1,548K
(-12.94%↓ Y/Y)
Total revenue
$27,925K
(-6.70%↓ Y/Y)
Operating loss
-$23,269K
(-31.09%↓ Y/Y)
Gross profit
$11,804K
(-4.02%↓ Y/Y)
Cost of products and
services sold
$16,121K
(-8.57%↓ Y/Y)
Total operating
expenses
$35,073K
(16.72%↑ Y/Y)
General and
administrative
$14,556K
(3.22%↑ Y/Y)
Research and development
$13,654K
(42.18%↑ Y/Y)
Sales and marketing
$6,770K
(-1.30%↓ Y/Y)
Change in the estimated
fair value of...
$93K
(-80.54%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ORASURE TECHNOLOGIES INC (OSUR)
ORASURE TECHNOLOGIES INC (OSUR)